The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
The DOI matches its Crossref record; 218 of the 220 references it cites were found in a registry or an index.
Abstract
Beside the well-known deficiency in serotonergic neurotransmission as pathophysiological correlate of major depression (MD), recent evidence points to a pivotal role of increased glutamate receptor activation as well. However, cause and interaction of these neurotransmitter alterations are not understood. In this review, we present a hypothesis integrating current concepts of neurotransmission and hypothalamus-pituitary-adrenal (HPA) axis dysregulation with findings on immunological alterations and alterations in brain morphology in MD. An immune activation including increased production of proinflammatory cytokines has repeatedly been described in MD. Proinflammatory cytokines such as interleukin-2, interferon-gamma, or tumor necrosis factor-alpha activate the tryptophan- and serotonin-degrading enzyme indoleamine 2,3-dioxygenase (IDO). Depressive states during inflammatory somatic disorders are also associated with increased proinflammatory cytokines and increased consumption of tryptophan via activation of IDO. An enhanced consumption of serotonin and its precursor tryptophan through IDO activation could well explain the reduced availability of serotonergic neurotransmission in MD. An increased activation of IDO and its subsequent enzyme kynurenine monooxygenase by proinflammatory cytokines, moreover, leads to an enhanced production of quinolinic acid, a strong agonist of the glutamatergic N-methyl-D-aspartate receptor. In inflammatory states of the central nervous system, IDO is mainly activated in microglial cells, which preferentially metabolize tryptophan to the NMDA receptor agonist quinolinic acid, whereas astrocytes - counteracting this metabolism due to the lack of an enzyme of this metabolism - have been observed to be reduced in MD. Therefore the type 1/type 2 immune response imbalance, associated with an astrocyte/microglia imbalance, leads to serotonergic deficiency and glutamatergic overproduction. Astrocytes are further strongly involved in re-uptake and metabolic conversion of glutamate. The reduced number of astrocytes could contribute to both, a diminished counterregulation of IDO activity in microglia and an altered glutamatergic neurotransmission. Further search for antidepressant agents should take into account anti-inflammatory drugs, for example, cyclooxygenase-2 inhibitors, might exert antidepressant effects by acting on serotonergic deficiency, glutamatergic hyperfunction and antagonizing neurotoxic effects of quinolinic acid.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An alternative explanation for the involvement of IDO in the pathophysiology of depression-like behaviour is that degradation of tryptophan along the kynurenine pathway generates compounds that act as either agonists (for example, quinolinic acid and 3 hydroxy-kynurenine) or antagonists (for example, kynurenic acid) of the NMDA (N-methyl-D-aspartate) receptor (BOX 1).”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [61]
In the citing paper
“cytokine-induced activation of the enzyme, indolamine 2,3 dioxygenase (IDO), which metabolizes tryptophan to kynurenine and quinolinic acid, is believed to contribute to reduced availability of serotonin.16,23,24”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [23]
In the citing paper
“one hypothesis postulates that proinflammatory cytokines stimulate indoleamine 2,3-dioxygenase (IDO) in glial cells to convert tryptophan to kynurenine which is transformed into the neurotoxic quinolinic acid inside the brain (Müller and Schwarz, 2007;Walker et al., 2014).”
From A Review of the Relationship between Proinflammatory Cytokines and Major Depressive Disorder (2014) · cites this paper as Müller and Schwarz, 2007
In the citing paper
“kynurenic acid is an N-methyl d-aspartate (NMDA) receptor antagonist, and is generally considered neuroprotective”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Müller and Schwarz, 2007
Citations
Cites
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Davis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
Munn, D. H., Shafizadeh, E., Attwood, J. T., Bondarev, I., Pashine, A., & Mellor, A. L. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.9.1363 · Cited by 1,623
Glial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Cytokine-Associated Emotional and Cognitive Disturbances in Humans
Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., Morag, A., & Pollmächer, T. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.445 · Cited by 1,365
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Depression and cortisol responses to psychological stress: A meta-analysis
Burke, H. M., Davis, M. C., Otte, C., & Mohr, D. C. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.02.010 · Cited by 1,194
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
Discovering Endophenotypes for Major Depression
Hasler, G., Drevets, W. C., Manji, H. K., & Charney, D. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300506 · Cited by 1,123
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Woolley, C. S., Gould, E., & McEwen, B. S. (1990) · Brain Research · doi:10.1016/0006-8993(90)90778-a · Cited by 1,020
Evidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Life Events and Depression: A Controlled Study
Paykel, E. S. (1969) · Archives of General Psychiatry · doi:10.1001/archpsyc.1969.01740240113014 · Cited by 968
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Depression and immunity: A meta-analytic review.
Herbert, T. B., & Cohen, S. (1993) · Psychological Bulletin · doi:10.1037/0033-2909.113.3.472 · Cited by 803
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Self-citationFunctional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785
Tolerance, DCs and tryptophan: much ado about IDO
Grohmann, U. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00072-3 · Cited by 766
Size of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Mathur, R. (2004) · Drug Screening Methods · doi:10.5005/jp/books/10243_6 · Cited by 665
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., Myers, R. M., Bunney, W. E., Akil, H., Watson, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507901102 · Cited by 652
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
Mellor, A. L., & Munn, D. H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01520-0 · Cited by 648
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622
Marzi, M., Vigano, A., Trabattoni, D., Villa, M. L., Salvaggio, A., Clerici, E., & Clerici, M. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-809.x · Cited by 616
Heyes, M. P., Brew, B. J., Martin, A., Price, R. W., Salazar, A. M., Sidtis, J. J., Yergey, J. A., Mouradian, M. M., Sadler, A. E., Keilp, J., et al. (1991) · Annals of Neurology · doi:10.1002/ana.410290215 · Cited by 571
Rajkowska, G., Halaris, A., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 570
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562
Johnston-Wilson, N. L., Sims, C. D., Hofmann, J.-P., Anderson, L., Shore, A. D., Torrey, E. F., Yolken, R. H., & the Stanley Neuropathology Consortium (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000696 · Cited by 531
Penninx, B. W. J. H., Kritchevsky, S. B., Yaffe, K., Newman, A. B., Simonsick, E. M., Rubin, S., Ferrucci, L., Harris, T., & Pahor, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01811-5 · Cited by 530
Zhou, D., Kusnecov, A. W., Shurin, M. R., DePaoli, M., & Rabin, B. S. (1993) · Endocrinology · doi:10.1210/endo.133.6.8243274 · Cited by 494
Interferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473
Prevalence of depressive symptoms in late pregnancy and postpartum
Josefsson, A., Berg, G., Nordin, C., & Sydsjö, G. (2001) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2001.080003251.x · Cited by 466
Exposure to Acute Stress Induces Brain Interleukin-1β Protein in the Rat
Nguyen, K. T., Deak, T., Owens, S. M., Kohno, T., Fleshner, M., Watkins, L. R., & Maier, S. F. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02239.1998 · Cited by 460
Wichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., Pearce, B. D., Landry, J., Glover, S., McDaniel, J. S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1252 · Cited by 445
Maes, M., Scharpé, S., Meltzer, H. Y., Bosmans, E., Suy, E., Calabrese, J., & Cosyns, P. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90027-e · Cited by 439
Czéh, B., Simon, M., Schmelting, B., Hiemke, C., & Fuchs, E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300982 · Cited by 434
Saito, S., Sakai, M., Sasaki, Y., Tanebe, K., Tsuda, H., & Michimata, T. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00997.x · Cited by 425
Sapolsky, R. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01228.1985 · Cited by 400
Aloisi, F., Ria, F., & Adorini, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01512-1 · Cited by 392
Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392
A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation
Braun, D., Longman, R. S., & Albert, M. L. (2005) · Blood · doi:10.1182/blood-2005-03-0979 · Cited by 391
Tuglu, C., Kara, S. H., Caliyurt, O., Vardar, E., & Abay, E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1566-z · Cited by 391
Indicators of immune activation in major depression
Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghmans, R., Maes, M., & Wiktorowicz, K. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02783-7 · Cited by 384
Immunoregulators in the nervous system
Plata-Salamán, C. R. (1991) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80001-6 · Cited by 380
Glucocortcoids mediate the stress-induced extracellular accumulation of glutamate
Moghaddam, B., Bolinao, M. L., Stein-Behrens, B., & Sapolsky, R. (1994) · Brain Research · doi:10.1016/0006-8993(94)91622-5 · Cited by 378
Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression
Myint, A. M., & Kim, Y. K. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00207-x · Cited by 374
Alesci, S., Martinez, P. E., Kelkar, S., Ilias, I., Ronsaville, D. S., Listwak, S. J., Ayala, A. R., Licinio, J., Gold, H. K., Kling, M. A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1667 · Cited by 372
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Effects of antidepressants on the production of cytokines
Kenis, G., & Maes, M. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003164 · Cited by 370
Indoleamine 2,3-dioxygenase. Purification and some properties
Shimizu, T., Nomiyama, S., Hirata, F., & Hayaishi, O. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30447-7 · Cited by 367
Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Maes, M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357
Cerebrospinal Cytokine Levels in Patients with Acute Depression
Levine, J., Barak, Y., Chengappa, K. N. R., Rapoport, A., Rebey, M., & Barak, V. (1999) · Neuropsychobiology · doi:10.1159/000026615 · Cited by 354
Fever and hypothermia in systemic inflammation: recent discoveries and revisions
Romanovsky, A. (2005) · Frontiers in Bioscience · doi:10.2741/1690 · Cited by 344
Kubera, M., Lin, A.-H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00012 · Cited by 343
Miguel-Hidalgo, J. J., Baucom, C., Dilley, G., Overholser, J. C., Meltzer, H. Y., Stockmeier, C. A., & Rajkowska, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00999-9 · Cited by 336
The immune system, depression and the action of antidepressants
Leonard, B. E. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00155-5 · Cited by 333
Fava, G. A., Munari, F., Pavan, L., & Kellner, R. (1981) · Journal of Affective Disorders · doi:10.1016/0165-0327(81)90040-9 · Cited by 330
(1993) · PubMed · Cited by 330
Haack, M., Hinze-Selch, D., Fenzel, T., Kraus, T., Kühn, M., Schuld, A., & Pollmächer, T. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00021-7 · Cited by 329
An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression
Zarate, C. A., Payne, J. L., Quiroz, J., Sporn, J., Denicoff, K. K., Luckenbaugh, D., Charney, D. S., & Manji, H. K. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.171 · Cited by 324
Cytokines: abnormalities in major depression and implications for pharmacological treatment
O'Brien, S. M., Scott, L. V., & Dinan, T. G. (2004) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.609 · Cited by 320
Hauser, P., Khosla, J., Aurora, H., Laurin, J., Kling, M. A., Hill, J., Gulati, M., Thornton, A. J., Schultz, R. L., Valentine, A. D., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001119 · Cited by 313
Lespérance, F., Frasure-Smith, N., Théroux, P., & Irwin, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.271 · Cited by 309
Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine
SŁUŻEWSKA, A., RYBAKOWSKI, J. K., LACIAK, M., MACKIEWICZ, A., SOBIESKA, M., & WIKTOROWICV, K. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32372.x · Cited by 306
Mikova, O., Yakimova, R., Bosmans, E., Kenis, G., & Maes, M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00081-5 · Cited by 305
Maes, M., Scharpé, S., Meltzer, H. Y., Okayli, G., Bosmans, E., D'Hondt, P., Vanden Bossche, B., & Cosyns, P. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90003-5 · Cited by 302
Increase in Interleukin-1β in Late-Life Depression
Thomas, A. J., Davis, S., Morris, C., Jackson, E., Harrison, R., & O’Brien, J. T. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.175 · Cited by 291
Beyond Monoamines: Glutamatergic Function in Mood Disorders
Kugaya, A., & Sanacora, G. (2005) · CNS Spectrums · doi:10.1017/s1092852900010403 · Cited by 290
Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation
Kwidzinski, E., Bunse, J., Aktas, O., Richter, D., Mutlu, L., Zipp, F., Nitsch, R., & Bechmann, I. (2005) · The FASEB Journal · doi:10.1096/fj.04-3228fje · Cited by 289
Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A., & Rajkowska, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300525 · Cited by 268
Nowak, G., Ordway, G. A., & Paul, I. A. (1995) · Brain Research · doi:10.1016/0006-8993(95)00057-w · Cited by 262
Zarate, C. A., Quiroz, J. A., Singh, J. B., Denicoff, K. D., De Jesus, G., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.023 · Cited by 257
Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation
Pugh, C. (1999) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00098-4 · Cited by 246
Psychiatric Symptoms in Patients With Chronic Hepatitis C Receiving Interferon Alfa-2b Therapy
Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0614 · Cited by 245
Cytokine Production and Serum Proteins in Depression
SEIDEL, A., AROLT, V., HUNSTIGER, M., RINK, L., BEHNISCH, A., & KIRCHNER, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03604.x · Cited by 244
Physiological Elevations of Glucocorticoids Potentiate Glutamate Accumulation in the Hippocampus
Stein‐Behrens, B. A., Lin, W. J., & Sapolsky, R. M. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020596.x · Cited by 243
Plasma and platelet excitatory amino acids in psychiatric disorders
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243
Hestad, K. A., Tønseth, S., Støen, C. D., Ueland, T., & Aukrust, P. (2003) · The Journal of ECT · doi:10.1097/00124509-200312000-00002 · Cited by 235
Song, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Whelan, A., Cosyns, P., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00025-1 · Cited by 232
Mauri, M. C., Ferrara, A., Boscati, L., Bravin, S., Zamberlan, F., Alecci, M., & Invernizzi, G. (1998) · Neuropsychobiology · doi:10.1159/000026491 · Cited by 231
Hewett, S. J., Uliasz, T. F., Vidwans, A. S., & Hewett, J. A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39251-1 · Cited by 227
IL-6 levels decrease with SSRI treatment in patients with major depression
Basterzi, A. D., Aydemir, Ç., Kisa, C., Aksaray, S., Tuzer, V., Yazici, K., & Göka, E. (2005) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.717 · Cited by 219
Acute phase proteins in major depression
Berk, M., Wadee, A. A., Kuschke, R. H., & O'Neill-Kerr, A. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00139-6 · Cited by 215
Pollak, Y., & Yirmiya, R. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003152 · Cited by 215
Riluzole Enhances Glutamate Uptake in Rat Astrocyte Cultures
Frizzo, M. E. D. S., Dall'Onder, L. P., Dalcin, K. B., & Souza, D. O. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000012717.37839.07 · Cited by 212
Cytokines and serotonin transporter in patients with major depression
Tsao, C.-W., Lin, Y.-S., Chen, C.-C., Bai, C.-H., & Wu, S.-R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.01.029 · Cited by 211
Sleep associated regulation of T helper 1/T helper 2 cytokine balance in humans
Dimitrov, S., Lange, T., Tieken, S., Fehm, H. L., & Born, J. (2004) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2003.08.004 · Cited by 209
Robinson, C. M., Hale, P. T., & Carlin, J. M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.20 · Cited by 207
Depression, immunocompetence, and prostaglandins of the E series
Calabrese, J. R., Skwerer, R. G., Barna, B., Gulledge, A. D., Valenzuela, R., Butkus, A., Subichin, S., & Krupp, N. E. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90040-5 · Cited by 205
Maes, M., Verkerk, R., Bonaccorso, S., Ombelet, W., Bosmans, E., & Scharpé, S. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01853-2 · Cited by 203
Prolonged effect of an anesthetic dose of ketamine on behavioral despair
Yilmaz, A., Schulz, D., Aksoy, A., & Canbeyli, R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00693-1 · Cited by 199
Mohr, D. C., Goodkin, D. E., Islar, J., Hauser, S. L., & Genain, C. P. (2001) · Archives of Neurology · doi:10.1001/archneur.58.7.1081 · Cited by 190
Increased serum glutamate in depressed patients
Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H. (1982) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00345492 · Cited by 189
Small-Dose Ketamine Improves the Postoperative State of Depressed Patients
Kudoh, A., Takahira, Y., Katagai, H., & Takazawa, T. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200207000-00020 · Cited by 189
Alberati‐Giani, D., Ricciardi‐Castagnoli, P., Köhler, C., & Cesura, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66030996.x · Cited by 187
Th2 Cytokine Response in Major Depressive Disorder Patients before Treatment
Pavón, L., Sandoval-López, G., Eugenia Hernández, M., Loría, F., Estrada, I., Pérez, M., Moreno, J., Ávila, U., Leff, P., Antón, B., et al. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.08.014 · Cited by 187
A mechanism for increased quinolinic acid formation following acute systemic immune stimulation
Saito, K., Crowley, J. S., Markey, S. P., & Heyes, M. P. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82284-0 · Cited by 184
CSF corticotropin-releasing hormone in depressed patients and normal control subjects
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.5.641 · Cited by 183
Maes, M., Verkerk, R., Vandoolaeghe, E., Lin, A., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10004.x · Cited by 179
Kaestner, F., Hettich, M., Peters, M., Sibrowski, W., Hetzel, G., Ponath, G., Arolt, V., Cassens, U., & Rothermundt, M. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.03.012 · Cited by 176
SALAS, M. A., EVANS, S. W., LEVELL, M. J., & WHICHER, J. T. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb08114.x · Cited by 176
Takahashi, T., Kimoto, T., Tanabe, N., Hattori, T., Yasumatsu, N., & Kawato, S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01251.x · Cited by 176
Casolini, P., Catalani, A., Zuena, A. R., & Angelucci, L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10192 · Cited by 174
Fast Removal of Synaptic Glutamate by Postsynaptic Transporters
Auger, C., & Attwell, D. (2000) · Neuron · doi:10.1016/s0896-6273(00)00132-x · Cited by 172
Raised levels of plasma interleukin‐1β in major and postviral depression
Owen, B. M., Eccleston, D., Ferrier, I. N., & Young, H. (2001) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2001.00162.x · Cited by 165
MIF Expression in the Rat Brain: Implications for Neuronal Function
Bacher, M., Meinhardt, A., Lan, H. Y., Dhabhar, F. S., Mu, W., Metz, C. N., Chesney, J. A., Gemsa, D., Donnelly, T., Atkins, R. C., et al. (1998) · Molecular Medicine · doi:10.1007/bf03401919 · Cited by 163
Immune Correlates of Depression
Irwin, M. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_1 · Cited by 162
Sundar, S., Cierpial, M., Kilts, C., Ritchie, J., & Weiss, J. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-11-03701.1990 · Cited by 157
Different immune patterns in melancholic and non-melancholic major depression
Rothermundt, M., Arolt, V., Fenker, J., Gutbrodt, H., Peters, M., & Kirchner, H. (2001) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060170058 · Cited by 157
Heyes, M. P., Saito, K., Lackner, A., Wiley, C. A., Achim, C. L., & Markey, S. P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.881 · Cited by 153
CSF Prostaglandin Levels in Depressed and Schizophrenic Patients
Linnoila, M. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790040059008 · Cited by 151
Effects of MK-801 and antidepressant drugs in the forced swimming test in rats
Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1992) · European Neuropsychopharmacology · doi:10.1016/0924-977x(92)90034-6 · Cited by 150
Nudmamud‐Thanoi, S., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.035 · Cited by 150
Lane, J. H., Sasseville, V. G., Smith, M. O., Vogel, P., Pauley, D. R., Heyes, M. P., & Lackner, A. A. (1996) · Journal of NeuroVirology · doi:10.3109/13550289609146909 · Cited by 147
Yaron, I., Shirazi, I., Judovich, R., Levartovsky, D., Caspi, D., & Yaron, M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199912)42:12<2561::aid-anr8>3.0.co;2-u · Cited by 147
Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression
Maes, M. H. J., Meltzer, H. Y., Buckley, P. F., & Bosmans, E. (1995) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02190412 · Cited by 143
Increased level of salivary prostaglandins in patients with major depression
Ohishi, K., Ueno, R., Nishino, S., Sakai, T., & Hayaishi, O. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90283-1 · Cited by 142
Yan, Q., Reith, M. E. A., Jobe, P. C., & Dailey, J. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00568-4 · Cited by 141
Fatemi, S. H., Laurence, J. A., Araghi-Niknam, M., Stary, J. M., Schulz, S. C., Lee, S., & Gottesman, I. I. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2003.08.014 · Cited by 141
Interferons and indoleamine 2,3-dioxygenase: Role in antimicrobial and antitumor effects
Carlin, J. M., Ozaki, Y., Byrne, G. I., Brown, R. R., & Borden, E. C. (1989) · Cellular and Molecular Life Sciences · doi:10.1007/bf01990503 · Cited by 140
WEISS, G., MURR, C., ZOLLER, H., HAUN, M., WIDNER, B., LUDESCHER, C., & FUCHS, D. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00910.x · Cited by 139
The pattern of mental change and body weight change in the first post-partum week
Stein, G. S. (1980) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(80)90038-0 · Cited by 137
Coric, V., Milanovic, S. M., Wasylink, S., Patel, P., Malison, R. T., & Krystal, J. H. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1396-z · Cited by 136
Increased soluble interleukin‐2 receptor concentrations in suicide attempters
Nässberger, L., & Träskman‐Bendz, L. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03412.x · Cited by 133
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128
Blood levels of cytokines in elderly patients with major depressive disorder
Brambilla, F., & Maggioni, M. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10005.x · Cited by 128
Regulation of glutamate transporters in health and disease
Gegelashvili, G., Robinson, M. B., Trotti, D., & Rauen, T. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32082-4 · Cited by 127
CYLOSERINE AS AN ANTIDEPRESSANT AGENT
CRANE, G. E. (1959) · American Journal of Psychiatry · doi:10.1176/ajp.115.11.1025 · Cited by 127
Major depressive disorder is associated with elevated monocyte counts
Seidel, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09849.x · Cited by 123
Østensen, M., Förger, F., Nelson, J. L., Schuhmacher, A., Hebisch, G., & Villiger, P. M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.029538 · Cited by 122
Cytokine profiles in women with different subtypes of major depressive disorder
Marques-Deak, A., NETO, F., Dominguez, W. V., Solis, A. C. D. O., Kurcgant, D., Sato, F. P., Ross, J. M., & Prado, E. D. F. G. B. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.11.003 · Cited by 120
Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder
Scarr, E., Pavey, G., Sundram, S., MacKinnon, A., & Dean, B. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00024.x · Cited by 120
Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats
Martin, P., Carlsson, M. L., & Hjorth, S. (1998) · NeuroReport · doi:10.1097/00001756-199809140-00012 · Cited by 118
Katila, H., Appelberg, B., Hurme, M., & Rimón, R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90081-7 · Cited by 116
Depression: What We can Learn from Postmortem Studies
Rajkowska, G. (2003) · The Neuroscientist · doi:10.1177/1073858403252773 · Cited by 115
Obuchowicz, E., Kowalski, J., Labuzek, K., Krysiak, R., Pendzich, J., & Herman, Z. S. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500547x · Cited by 115
Jun, T.-Y., Pae, C.-U., Hoon-Han, &., Chae, J.-H., Bahk, W.-M., Kim, K.-S., & Serretti, A. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00008 · Cited by 113
Niino, M., Ogata, A., Kikuchi, S., Tashiro, K., & Nishihira, J. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00397-x · Cited by 109
Müller, N., Hofschuster, E., Ackenheil, M., Mempel, W., & Eckstein, R. (1993) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(93)90055-w · Cited by 106
Self-citation(1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.3.270 · Cited by 106
Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
Dieperink, E., Ho, S. B., Tetrick, L., Thuras, P., Dua, K., & Willenbring, M. L. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.01.003 · Cited by 106
Cao, C., Matsumura, K., Ozaki, M., & Watanabe, Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00716.1999 · Cited by 105
Increased CD56+Natural Killer Cells and Related Cytokines in Major Depression
Seide, A., Arolt, V., Hunstiger, M., Rink, L., Behnisch, A., & Kirchner, H. (1996) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.0012 · Cited by 104
Amantadine as augmentation therapy in the management of treatment-resistant depression
Stryjer, R., Strous, R. D., Shaked, G., Bar, F., Feldman, B., Kotler, M., Polak, L., Rosenzcwaig, S., & Weizman, A. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00005 · Cited by 103
Thomas, A. J., Ferrier, I. N., Kalaria, R. N., Woodward, S. A., Ballard, C., Oakley, A., Perry, R. H., & O’Brien, J. T. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1682 · Cited by 102
Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder
Pike, J. L., & Irwin, M. R. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2005.05.004 · Cited by 101
Possible Use of Amantadine in Depression
Huber, T., Dietrich, D., & Emrich, H. (1999) · Pharmacopsychiatry · doi:10.1055/s-2007-979191 · Cited by 97
Immune consequences of the spontaneous pro-inflammatory status in depressed elderly patients
Trzonkowski, P., Myśliwska, J. M., Godlewska, B. R., Szmit, E., Łukaszuk, K., Więckiewicz, J., Brydak, L. B., Machała, M. K., Landowski, J., & Myśliwski, A. (2003) · Brain Behavior and Immunity · doi:10.1016/s0889-1591(03)00111-9 · Cited by 94
Rieckmann, P., Nünke, K., Burchhardt, M., Albrecht, M., Wiltfang, J., Ulrich, M., & Felgenhauer, K. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90023-r · Cited by 93
Kagaya, A., Kugaya, A., Takebayashi, M., Fukue-Saeki, M., Saeki, T., Yamawaki, S., & Uchitomi, Y. (2001) · Neuropsychobiology · doi:10.1159/000054867 · Cited by 92
Dunbar, P. R., Hill, J., Neale, T. J., & Mellsop, G. W. (1992) · Psychological Medicine · doi:10.1017/s0033291700038629 · Cited by 89
Narita, K., Murata, T., Takahashi, T., Kosaka, H., Omata, N., & Wada, Y. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.030 · Cited by 88
Antidepressant Effect of Ketamine During ECT
Ostroff, R. B., GONZALES, M., & Sanacora, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1385 · Cited by 87
The Involvement of Glutamate in the Pathophysiology of Depression
(2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.4.908661 · Cited by 86
Immune and hormonal activity in adults suffering from depression
Nunes, S. O. V., Reiche, E. M. V., Morimoto, H. K., Matsuo, T., Itano, E. N., Xavier, E. C. D., Yamashita, C. M., Vieira, V. R., Menoli, A. V., Silva, S. S., et al. (2002) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2002000500011 · Cited by 80
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
A Multivariate Investigation of Postpartum Mood Disturbance
Gard, P. R., Handley, S. L., Parsons, A. D., & Waldron, G. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.148.5.567 · Cited by 78
Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues
Kohl, C. A., Walch, T., Huber, R., Kemmler, G., Neurauter, G., Fuchs, D., Sölder, E., Schröcksnadel, H., & Sperner‐Unterweger, B. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.013 · Cited by 78
Handbook of Depression and Anxiety
(2003) · CRC Press eBooks · doi:10.3109/9780203911822 · Cited by 78
Urinary excretion of bioterin and neopterin in psychiatric disorders
Duch, D. S., Woolf, J. H., Nichol, C. A., Davidson, J. R. T., & Garbutt, J. C. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90090-8 · Cited by 77
Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study
Davis, S. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.5.556 · Cited by 77
Effect of rofecoxib on nociception and the serotonin system in the rat brain
Sandrini, M., Vitale, G., & Pini, L. A. (2002) · Inflammation Research · doi:10.1007/pl00000287 · Cited by 76
Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function
Hu, F., Wang, X., Pace, T. W. W., Wu, H., & Miller, A. H. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001644 · Cited by 76
Schaefer, M., Horn, M., Schmidt, F., Schmid-Wendtner, M.-H., Volkenandt, M., Ackenheil, M., Mueller, N., & Schwarz, M. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.02.002 · Cited by 75
Self-citationReichenberg, A., Kraus, T., Haack, M., Schuld, A., Pollmächer, T., & Yirmiya, R. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00101-9 · Cited by 74
Rosa, A., Peralta, V., Papiol, S., Cuesta, M. J., Serrano, F., Martínez‐Larrea, A., & Fañanás, L. (2004) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20074 · Cited by 72
Riluzole Augmentation for Treatment-Resistant Depression
Sanacora, G., Kendell, S. F., Fenton, L. R., Coric, V., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.11.2132 · Cited by 72
Immune activation in non-treated suicidal major depression
Mendlovic, S., Mozes, E., Eilat, E., Doron, A., Lereya, J., Zakuth, V., & Spirer, Z. (1999) · Immunology Letters · doi:10.1016/s0165-2478(98)00145-x · Cited by 69
Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers
Bonaccorso, S., Lin, A. H., Verkerk, R., Hunsel, F. V., Libbrecht, I., Scharpé, S., DeClerck, L., Biondi, M., Janca, A., & Maes, M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00144-4 · Cited by 69
Garza, R. D. L., & Asnis, G. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02757-4 · Cited by 67
Hypothesis: Low Serum Cholesterol, Suicide, and lnterleukin-2
Penttinen, J. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117492 · Cited by 67
FITZGERALD, P., O'BRIEN, S. M., SCULLY, P., RIJKERS, K., SCOTT, L. V., & DINAN, T. G. (2006) · Psychological Medicine · doi:10.1017/s003329170500632x · Cited by 66
In vitro immunoregulatory effects of antidepressants in healthy volunteers.
Szuster‐Ciesielska, A., Tustanowska-Stachura, A., Słotwińska, M., Marmurowska-Michałowska, H., & Kandefer‐Szerszeń, M. (2003) · PubMed · Cited by 66
Neurokynurenines (Neky) as Common Neurochemical Links of Stress and Anxiety
Lapin, I. P. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0135-0_14 · Cited by 65
Relationship between cyclooxygenase‐2 and nitric oxide synthase‐2 in rat cortex after stress
Madrigal, J. L. M., García‐Bueno, B., Moro, M. A., Lizasoain, I., Lorenzo, P., & Leza, J. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02888.x · Cited by 64
Brenhouse, H. C., Chen, E., Emerich, D. F., Baldwin, S., Hogeland, K., Ranelli, S., Lafreniere, D., Perdomo, B., Novak, L., Kladis, T., et al. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049700 · Cited by 63
Xiao, B., & Link, H. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01501-7 · Cited by 60
Stübner, S., Schön, T., Padberg, F., Teipel, S. J., Schwarz, M. J., Haslinger, A., Buch, K., Dukoff, R., Lasser, R., Müller, N., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00916-1 · Cited by 59
Self-citationMiyahara, S., Komori, T., Fujiwara, R., Shizuya, K., Yamamoto, M., Ohmori, M., & Okazaki, Y. (2000) · Life Sciences · doi:10.1016/s0024-3205(99)00626-8 · Cited by 58
Collantes-Estevez, E., & Fernandez-Perez, C. (2003) · Current Medical Research and Opinion · doi:10.1185/030079903125001938 · Cited by 52
Briley, M., & Fillion, G. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199001000-00013 · Cited by 52
LIVER AND BRAIN TRYPTOPHAN METABOLISM FOLLOWING HYDROCORTISONE ADMINISTRATION TO RATS AND GERBILS
Green, A. R., Sourkes, T. L., & Young, S. N. (1975) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1975.tb07360.x · Cited by 51
Cassano, P., Hidalgo, A., Burgos, V. L., Adris, S., & Argibay, P. F. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500385 · Cited by 50
Schlatter, J., Ortuño, F., & Cervera‐Enguix, S. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.06.004 · Cited by 48
Martin, A. D., Heyes, M. P., Salazar, A. Μ., Law, W. A., & Williams, J. (1993) · Neuropsychology · doi:10.1037/0894-4105.7.2.149 · Cited by 48
Suzuki, T., Ogata, A., Tashiro, K., Nagashima, K., Tamura, M., Yasui, K., & Nishihira, J. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00262-1 · Cited by 47
Handbook of depression and anxiety
Kasper, S. F., den Boer, J. A., & Sitsen, J. M. A. (2003) · M. Dekker eBooks · Cited by 46
Chen, Q., Surmeier, D. J., & Reiner, A. J. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7135 · Cited by 44
Fundamentals of Psychoneuroimmunology
Pariante, C. M. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2001.01333.x · Cited by 43
Fundamentals of Psychoneuroimmunology
Song, C., & Leonard, B. E. (2000) · Cited by 43
Research works printed but not linked: 5
- Matussek N . Neurobiologie und depression. Med Monatsschr 1966; 3: 109–112.
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Anderson DN . The role of pterins and related factors in the biology of early postpartum depression. Eur Neuropsychopharmacol 1999; 9: 295–300.
- Rajkowska G . Astroglia in the cortex of schizophrenics: histopathology finding. World J Biol Psychiatry 2005; 6: 74.
- Thomas K . Immunomodulation in Mice Induced by the Antidepressant Drug Zimeldine. Thesis, University of Utrecht: Utrecht, 1989.
- Song C, Leonard BE . An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 1994; 22: 313–314.
Cited by
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
“Quinolinic acid also induces oxidative stress, which in combination with glutamate release may contribute to CNS excitotoxicity (see below) (36,40-42).”
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382
O'Connor, J. C., Lawson, M. A., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002148 · Cited by 1,278
Metadata
- Authors
- Müller, N., & Schwarz, M. J.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- Venue
- Molecular Psychiatry
- Published
- 2007-04-24
- Volume
- 12
- Issue
- 11
- Pages
- 988-1000
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2002250647
- Cited by
- 670
- References
- 220
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 30 · 2023: 31 · 2022: 48 · 2021: 41 · 2020: 37 · 2019: 34 · 2018: 42 · 2017: 25 · 2016: 49 · 2015: 34 · 2014: 39 · 2013: 32 · 2012: 33
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, serotonin, glutamate, indoleamine 2,3-dioxygenase, kynurenine pathway, quinolinic acid, NMDA receptor, inflammatory cytokines, microglia, astrocytes, tryptophan metabolism, hypothalamic-pituitary-adrenal axis, immune activation, antidepressants, COX-2 inhibitors
- MeSH terms
- Animals, Depression, Humans, Hypothalamo-Hypophyseal System, Immune System, Pituitary-Adrenal System, Serotonin, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.